Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RARB | P10826 | 8/20 | 0.51 |
| ▸ | RARG | P13631 | 7/20 | 0.51 |
| ▸ | RARA | P10276 | 5/20 | 0.51 |
| ▸ | CYP26A1 | O43174 | 4/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.51 |
| ▸ | CRABP2 | P29373 | 1/20 | 0.51 |
| ▸ | RXRA | P19793 | 10/20 | 0.48 |
| ▸ | RXRB | P28702 | 6/20 | 0.48 |
| ▸ | RXRG | P48443 | 5/20 | 0.48 |
| ▸ | CYP26B1 | Q9NR63 | 3/20 | 0.44 |
| ▸ | PPARG | P37231 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6378170 | 0.99 | RARB (0.52) | RARBRARGRARACYP26A1CYP3A4 | |
| Diethanolamine SCHEMBL7753391 | 0.91 | RARB (0.45) | RARBRARGRARACYP26A1CYP3A4 | |
| SCHEMBL7753400 | 0.88 | RARG (0.43) | RARBRARGRARACYP26A1CYP3A4 | |
| Lithium Ion SCHEMBL7751288 | 0.88 | CYP26A1 (0.44) | RARBRARGRARACYP26A1CYP3A4 | |
| SCHEMBL7746475 | 0.87 | RARG (0.55) | RARBRARGRARACYP26A1CYP3A4 | |
| SCHEMBL7752278 | 0.87 | CYP3A4 (0.44) | RARBRARGRARACYP26A1CYP3A4 | |
| SCHEMBL7751252 | 0.87 | CYP26A1 (0.44) | RARBRARGRARACYP26A1CYP3A4 | |
| SCHEMBL7751144 | 0.86 | RXRA (0.40) | RARBRARGRARACYP26A1CYP3A4 | |
| SCHEMBL19342932 | 0.85 | RARB (0.68) | RARBRARGRARACYP26A1CYP3A4 | |
| SCHEMBL7751123 | 0.85 | RXRA (0.46) | RARBRARGRARACYP26A1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6313162-B1 | FOR USE IN HUMAN OR VETERINARY MEDICINE SUCH AS DERMATOLOGICAL, RHEUMATIC, RESPIRATORY, CARDIOVASCULAR AND OPHHALMOLOGICAL DISORDERS; AND IN COSMETICS | CENTRE INTERNATIONAL DE RECHERCHE DERMATOLOGIQUES GALDERMA (C.I.R.D.) GALDERMA (FR) | 2001-11-06 | — | — | US | claimed |
| EP-0832057-B1 | DIAROMATIC PROPYNYL OR DIENYL COMPOUNDS | CT INTERNAT DE (FR) | 2001-01-03 | — | — | EP | claimed |
| US-6046220-A | ADMINISTERING TO THE PATIENT A PROPYNYL OR DIENYL BIAROMATIC COMPOUND TO TREAT A SKIN DISORDER, INFLAMMATORY CONDITIONS, VISION DEFECTS, ALOPECIA, CARDIOVASCULAR DISORDER, CANCER OR PRECANCER AND INSULIN DEPENDANT DIABETES | CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (FR) | 2000-04-04 | — | — | US | claimed |
| US-6313162-B1 | FOR USE IN HUMAN OR VETERINARY MEDICINE SUCH AS DERMATOLOGICAL, RHEUMATIC, RESPIRATORY, CARDIOVASCULAR AND OPHHALMOLOGICAL DISORDERS; AND IN COSMETICS | CENTRE INTERNATIONAL DE RECHERCHE DERMATOLOGIQUES GALDERMA (C.I.R.D.) GALDERMA (FR) | 2001-11-06 | — | — | US | disclosed |
| US-6046220-A | ADMINISTERING TO THE PATIENT A PROPYNYL OR DIENYL BIAROMATIC COMPOUND TO TREAT A SKIN DISORDER, INFLAMMATORY CONDITIONS, VISION DEFECTS, ALOPECIA, CARDIOVASCULAR DISORDER, CANCER OR PRECANCER AND INSULIN DEPENDANT DIABETES | CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (FR) | 2000-04-04 | — | — | US | disclosed |